Quick Answer
MEDICINOVA INC reported Total Assets of $45.60 million for the year ending 2025.
- MEDICINOVA INC showed a decrease of -18.4% in Total Assets from 2024 to 2025.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $27.16 million | Q3 2011: $24.64 million | Q1 2012: $26.91 million | Q2 2012: $23.03 million | Q3 2012: $21.50 million | Q1 2013: $18.85 million | Q2 2013: $27.68 million | Q3 2013: $26.20 million | Q1 2014: $31.22 million | Q2 2014: $29.56 million | Q3 2014: $27.79 million | Q1 2015: $25.47 million | Q2 2015: $24.72 million | Q3 2015: $39.59 million | Q1 2016: $43.86 million | Q2 2016: $42.36 million | Q3 2016: $40.78 million | Q1 2017: $37.42 million | Q2 2017: $38.46 million | Q3 2017: $40.11 million | Q1 2018: $78.66 million | Q2 2018: $79.08 million | Q3 2018: $77.28 million | Q1 2019: $78.55 million | Q2 2019: $77.15 million | Q3 2019: $78.22 million | Q1 2020: $77.01 million | Q2 2020: $75.84 million | Q3 2020: $77.29 million | Q1 2021: $96.10 million | Q2 2021: $93.68 million | Q3 2021: $91.62 million | Q1 2022: $84.18 million | Q2 2022: $81.24 million | Q3 2022: $78.39 million | Q1 2023: $71.13 million | Q2 2023: $68.72 million | Q3 2023: $68.14 million | Q1 2024: $62.89 million | Q2 2024: $60.40 million | Q3 2024: $58.12 million | Q1 2025: $52.43 million | Q2 2025: $49.82 million | Q3 2025: $47.58 million.
- Over the full 16 years of available data (2010 to 2025), MEDICINOVA INC's Total Assets has declined by 37.5%.
- Historical annual values: Fiscal year 2025: $45.60 million | Fiscal year 2024: $55.88 million | Fiscal year 2023: $66.27 million | Fiscal year 2022: $74.15 million | Fiscal year 2021: $87.41 million | Fiscal year 2020: $75.42 million | Fiscal year 2019: $79.21 million | Fiscal year 2018: $77.22 million | Fiscal year 2017: $43.42 million | Fiscal year 2016: $39.81 million | Fiscal year 2015: $37.91 million | Fiscal year 2014: $27.27 million | Fiscal year 2013: $29.55 million | Fiscal year 2012: $19.57 million | Fiscal year 2011: $30.79 million | Fiscal year 2010: $72.93 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: